Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Parfrey

Showing results (21-30 of 171) with videos related to

Pageof 18
Sort By:
Advances in Renal Replacement Therapy|July 1, 1997
Cardiac disease in chronic uremia: clinical outcome and risk factorsR N Foley, P S Parfrey
The Journal of Physiology|January 1, 1974
Proceedings: Individual facial areas in the human circulatory response to immersionP S Parfrey, J D Sheehan
Seminars in Nephrology|May 1, 1994
Cardiac disease in uremiaJ D Harnett, P S Parfrey
The New England Journal of Medicine|November 24, 1994
Prevention of nephrotoxicity induced by radiocontrast agentsB J Barrett, P S Parfrey
Current Opinion in Nephrology and Hypertension|December 14, 1999
Erythropoietin therapy in chronic uremia: the impact of normalization of hematocritS T Murphy, P S Parfrey
Current Opinion in Nephrology and Hypertension|November 1, 1996
Screening for cardiovascular disease in dialysis patientsS W Murphy, P S Parfrey
Journal of Nephrology|November 27, 1998
Cardiovascular disease and mortality in ESRDR N Foley, P S Parfrey
Journal of the American Society of Nephrology : JASN|July 11, 2001
Anemia in predialysis chronic renal failure: what are we treating?R N Foley, P S Parfrey
Current Opinion in Nephrology and Hypertension|September 1, 1995
Hypertension in autosomal dominant polycystic kidney diseaseP S Parfrey, B J Barrett
Current Opinion in Nephrology and Hypertension|March 1, 1994
The management of cardiac disease in chronic uremiaP S Parfrey, J D Harnett
Pageof 18

Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
Advances in Renal Replacement Therapy|July 1, 1997
Cardiac disease in chronic uremia: clinical outcome and risk factorsR N Foley, P S Parfrey
The Journal of Physiology|January 1, 1974
Proceedings: Individual facial areas in the human circulatory response to immersionP S Parfrey, J D Sheehan
Seminars in Nephrology|May 1, 1994
Cardiac disease in uremiaJ D Harnett, P S Parfrey
The New England Journal of Medicine|November 24, 1994
Prevention of nephrotoxicity induced by radiocontrast agentsB J Barrett, P S Parfrey
Current Opinion in Nephrology and Hypertension|December 14, 1999
Erythropoietin therapy in chronic uremia: the impact of normalization of hematocritS T Murphy, P S Parfrey
Current Opinion in Nephrology and Hypertension|November 1, 1996
Screening for cardiovascular disease in dialysis patientsS W Murphy, P S Parfrey
Journal of Nephrology|November 27, 1998
Cardiovascular disease and mortality in ESRDR N Foley, P S Parfrey
Journal of the American Society of Nephrology : JASN|July 11, 2001
Anemia in predialysis chronic renal failure: what are we treating?R N Foley, P S Parfrey
Current Opinion in Nephrology and Hypertension|September 1, 1995
Hypertension in autosomal dominant polycystic kidney diseaseP S Parfrey, B J Barrett
Current Opinion in Nephrology and Hypertension|March 1, 1994
The management of cardiac disease in chronic uremiaP S Parfrey, J D Harnett
Pageof 18